Fresita Proteins has finalized its upcoming rights issue to raise Rs 89.76 crore. The company will issue over 7.4 million new equity shares at Rs 120 per share. Existing shareholders as of October 30, 2026, are eligible to apply for 5 new shares for every 6 currently held.
Fresita Proteins Finalizes Rights Issue Terms
The company will raise Rs 89.76 crore through the issuance of 7,479,917 new equity shares.
The issue price is fixed at Rs 120 per share, including a premium of Rs 110.
Reader Takeaway: Existing shareholders can apply for 5 new shares for every 6 held; monitor the November 26 closing date.
What just happened
The Rights Issue Committee of Fresita Proteins Ltd has formally approved the terms for its rights issue. The company aims to bolster its capital base by issuing 7,479,917 fully paid-up equity shares at a face value of Rs 10 per share, priced at a premium. Shareholders who hold shares as of the record date, October 30, 2026, will be eligible to participate.
Why this matters
This capital infusion will expand the company's equity base from 8,975,900 shares to 16,455,817 shares, assuming full subscription. For retail investors, this is a significant corporate action that requires a decision on whether to subscribe to the rights, renounce them on the market, or allow them to lapse. The issue opens on November 12, 2026, and closes on November 26, 2026.
Key Dates to Watch
Investors should keep the following schedule in mind to ensure their participation:
- Record Date: October 30, 2026
- Issue Opening Date: November 12, 2026
- On-Market Renunciation Deadline: November 20, 2026
- Issue Closing Date: November 26, 2026
- Listing of New Shares: November 30, 2026
What changes now
Existing shareholders will see their holdings adjusted based on the 5:6 entitlement ratio. If the issue is fully subscribed, the increased equity capital will be integrated into the company's books by the end of November, impacting the overall share structure and potentially the earnings per share metrics moving forward.